Illinois Municipal Retirement Fund Decreases Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Illinois Municipal Retirement Fund trimmed its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 1.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 26,595 shares of the company’s stock after selling 503 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in Prestige Consumer Healthcare were worth $2,077,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of PBH. Kestra Investment Management LLC bought a new stake in shares of Prestige Consumer Healthcare in the 4th quarter worth approximately $27,000. Huntington National Bank increased its position in Prestige Consumer Healthcare by 39.9% in the third quarter. Huntington National Bank now owns 635 shares of the company’s stock worth $46,000 after buying an additional 181 shares during the last quarter. International Assets Investment Management LLC increased its position in Prestige Consumer Healthcare by 7,112.5% in the third quarter. International Assets Investment Management LLC now owns 1,154 shares of the company’s stock worth $83,000 after buying an additional 1,138 shares during the last quarter. Covestor Ltd raised its stake in shares of Prestige Consumer Healthcare by 95.6% in the third quarter. Covestor Ltd now owns 1,338 shares of the company’s stock valued at $96,000 after buying an additional 654 shares during the period. Finally, GAMMA Investing LLC lifted its position in shares of Prestige Consumer Healthcare by 18.9% during the 4th quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock valued at $108,000 after buying an additional 220 shares during the last quarter. 99.95% of the stock is owned by institutional investors.

Analyst Ratings Changes

PBH has been the subject of several recent research reports. Sidoti lowered Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective for the company. in a report on Monday, December 9th. Raymond James upgraded shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. DA Davidson boosted their price target on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research report on Friday, February 7th. StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Friday, January 24th. Finally, Canaccord Genuity Group boosted their target price on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a report on Friday, February 7th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, Prestige Consumer Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $92.60.

Prestige Consumer Healthcare Trading Up 1.0 %

Shares of Prestige Consumer Healthcare stock opened at $84.61 on Friday. The company’s 50-day moving average price is $80.04 and its 200-day moving average price is $77.14. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. Prestige Consumer Healthcare Inc. has a 12-month low of $62.35 and a 12-month high of $88.36. The company has a market cap of $4.19 billion, a price-to-earnings ratio of 19.81, a PEG ratio of 2.69 and a beta of 0.50.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. On average, equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.